Dual role for RhoA in suppression and induction of cytokines in the human neutrophil.

Abstract:

:Production of tumor necrosis factor-alpha (TNFalpha) by the neutrophil (PMN) is a pivotal event in innate immunity, but the signals regulating TNFalpha induction in this primary cell are poorly understood. Herein, we use protein transduction to identify novel, opposing anti- and pro-cytokine-inducing roles for RhoA in the resting and lipopolysaccharide (LPS)-stimulated human PMN, respectively. In the resting cell, RhoA suppresses Cdc42 activation, IkappaBalpha degradation, nuclear factor-kappaB (NF-kappaB) activation, and induction of TNFalpha and NF-kappaB-dependent chemokines. Suppression of TNFalpha induction by RhoA is Rho kinase alpha (ROCKalpha) independent, but Cdc42 dependent, because TNFalpha induction by C3 transferase is attenuated by inhibition of Cdc42, and constitutively active Cdc42 suffices to activate NF-kappaB and induce TNFalpha. By contrast, we also place RhoA downstream of p38 mitogen-activated protein kinase and Cdc42 in a novel LPS-activated pathway in which p38, Cdc42, and ROCKalpha all promote TNFalpha protein expression. The p65 subunit of NF-kappaB coprecipitates with RhoA in a manner sensitive to the RhoA activation state. Our findings suggest a new, 2-faced role for RhoA as a checkpoint in innate immunity.

journal_name

Blood

journal_title

Blood

authors

Fessler MB,Arndt PG,Just I,Nick JA,Malcolm KC,Worthen GS

doi

10.1182/blood-2006-03-012898

subject

Has Abstract

pub_date

2007-02-01 00:00:00

pages

1248-56

issue

3

eissn

0006-4971

issn

1528-0020

pii

blood-2006-03-012898

journal_volume

109

pub_type

杂志文章

相关文献

BLOOD文献大全
  • BCR ligation reprograms B cells for migration to the T zone and B-cell follicle sequentially.

    abstract::We have studied the impact of B-cell receptor (BCR) or CD40 ligation on the in vitro chemotactic response of tonsillar B cells to 4 chemokines: stromal cell-derived factor (SDF)-1alpha, macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and B-cell-attracting chemokine (BCA)-1. In the tonsil, SDF-1 and MIP-3alpha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.6.1913

    authors: Casamayor-Pallejà M,Mondière P,Verschelde C,Bella C,Defrance T

    更新日期:2002-03-15 00:00:00

  • Id1, but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance.

    abstract::E-proteins are widely expressed basic helix-loop-helix (HLH) transcription factors that regulate differentiation in many cell lineages, including lymphoid, muscle, and neuronal cells. E-protein function is controlled by HLH inhibitors such as Id and SCL/TAL1 proteins, which recently have been suggested to play a role ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-069914

    authors: Perry SS,Zhao Y,Nie L,Cochrane SW,Huang Z,Sun XH

    更新日期:2007-10-01 00:00:00

  • The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.

    abstract::Numerous studies have suggested that iron (Fe) chelators such as desferrioxamine (DFO) may be useful antitumor agents (Blatt and Stitely, Cancer Res 47:1749, 1987; Becton and Bryles, Cancer Res 48:7189, 1988). Recent work with several analogues of the lipophilic Fe chelator, pyridoxal isonicotinoyl hydrazone (PIH), in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Richardson DR,Tran EH,Ponka P

    更新日期:1995-12-01 00:00:00

  • Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections.

    abstract::We found an unusual fc gamma receptor IIIa (CD16) phenotype on the natural killer (NK) cells of a 3-year-old boy, who suffered from recurrent viral respiratory tract infections since birth. He also had severe clinical problems after Bacille Calmette-Geérin (BCG) vaccination and following Epstein-Barr virus and Varicel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: de Vries E,Koene HR,Vossen JM,Gratama JW,von dem Borne AE,Waaijer JL,Haraldsson A,de Haas M,van Tol MJ

    更新日期:1996-10-15 00:00:00

  • Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells.

    abstract::The clonal growth of progenitor cells from myelodysplastic syndromes (MDS) can be subdivided into four growth patterns: (1) normal, (2) no growth or low plating efficiency, (3) low colony and high cluster number, and (4) normal or high colony number with a large number of clusters. The former two (1 and 2) can be refe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sawada K,Ieko M,Notoya A,Tarumi T,Koizumi K,Kitayama S,Nishio H,Fukada Y,Yasukouchi T,Yamaguchi M,Katoh S,Koike T

    更新日期:1996-07-01 00:00:00

  • Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

    abstract::We report 2 novel, cryptic chromosomal abnormalities in precursor B-cell acute lymphoblastic leukemia (BCP-ALL): a translocation, either t(X;14)(p22;q32) or t(Y;14)(p11;q32), in 33 patients and an interstitial deletion, either del(X)(p22.33p22.33) or del(Y)(p11.32p11.32), in 64 patients, involving the pseudoautosomal ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-208397

    authors: Russell LJ,Capasso M,Vater I,Akasaka T,Bernard OA,Calasanz MJ,Chandrasekaran T,Chapiro E,Gesk S,Griffiths M,Guttery DS,Haferlach C,Harder L,Heidenreich O,Irving J,Kearney L,Nguyen-Khac F,Machado L,Minto L,Majid A,

    更新日期:2009-09-24 00:00:00

  • The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia.

    abstract::In patients with chronic lymphocytic leukemia (CLL), lenalidomide can promote humoral immune responses but also induces a distinct disease-specific toxicity of tumor flare and cytokine release. These CLL-specific events result from increased expression of costimulatory molecules on B cells. Here we demonstrate that le...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-315705

    authors: Herman SE,Lapalombella R,Gordon AL,Ramanunni A,Blum KA,Jones J,Zhang X,Lannutti BJ,Puri KD,Muthusamy N,Byrd JC,Johnson AJ

    更新日期:2011-04-21 00:00:00

  • Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells.

    abstract::The interleukin-6 receptor (IL-6R)/signal transducer and activator of transcription 3 (STAT3) pathway contributes to the pathogenesis of multiple myeloma (MM) and protects MM cells from apoptosis. However, MM cells survive the IL-6R blockade if they are cocultured with bone marrow stromal cells (BMSCs), suggesting tha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-04-1670

    authors: Chatterjee M,Stühmer T,Herrmann P,Bommert K,Dörken B,Bargou RC

    更新日期:2004-12-01 00:00:00

  • "You break it, you fix it.".

    abstract::Nonrandom chromosomal translocations are considered to be causal events leading to leukemic transformation. However, the mechanism(s) that cause these translocations are poorly understood. Libura and colleagues report exciting new findings on the mechanism(s) that lead to chromosomal translocation. ...

    journal_title:Blood

    pub_type: 评论,杂志文章,评审

    doi:10.1182/blood-2004-12-4760

    authors: Aplan PD

    更新日期:2005-03-01 00:00:00

  • RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses.

    abstract::The receptor for hyaluronic acid-mediated motility (RHAMM) is an antigen eliciting both humoral and cellular immune responses in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and multiple myeloma (MM). We initiated a phase 1 clinical trial vaccinating 10 patients with R3 (ILSLELMKL), a hi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-07-099366

    authors: Schmitt M,Schmitt A,Rojewski MT,Chen J,Giannopoulos K,Fei F,Yu Y,Götz M,Heyduk M,Ritter G,Speiser DE,Gnjatic S,Guillaume P,Ringhoffer M,Schlenk RF,Liebisch P,Bunjes D,Shiku H,Dohner H,Greiner J

    更新日期:2008-02-01 00:00:00

  • The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.

    abstract::We report the nonrandom occurrence, frequency, and degree of immunophenotype association of the t(1;14)(p34;q11) in children with acute lymphoblastic leukemia (ALL). This chromosomal abnormality occurred in leukemia cells from 5 of 1,630 (0.3%) consecutive children with newly diagnosed ALL who were entered on a single...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Carroll AJ,Crist WM,Link MP,Amylon MD,Pullen DJ,Ragab AH,Buchanan GR,Wimmer RS,Vietti TJ

    更新日期:1990-09-15 00:00:00

  • Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.

    abstract::The effect of donor/recipient histocompatibility on relapse in patients receiving T-cell-depleted (TCD) grafts for chronic myelogenous leukemia (CML) was evaluated. Specifically, we sought to determine whether TCD results in an attenuation of the graft-versus-leukemia (GVL) effect on recipients of unrelated marrow gra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hessner MJ,Endean DJ,Casper JT,Horowitz MM,Keever-Taylor CA,Roth M,Flomenberg N,Drobyski WR

    更新日期:1995-11-15 00:00:00

  • Mechanisms of organelle transport and capture along proplatelets during platelet production.

    abstract::Megakaryocytes generate platelets by remodeling their cytoplasm into long proplatelet extensions, which serve as assembly lines for platelet production. Platelet packaging and release concludes at the tips of each proplatelet. Essential in this process is the distribution of organelles and platelet-specific granules i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-06-2206

    authors: Richardson JL,Shivdasani RA,Boers C,Hartwig JH,Italiano JE Jr

    更新日期:2005-12-15 00:00:00

  • Bone marrow contains virus-specific cytotoxic T lymphocytes.

    abstract::Immunizing bone marrow donors prior to bone marrow transplant (BMT) has the potential for adoptively transferring specific immunity against opportunistic pathogens. Studies have shown that long-term antibody production occurs in the bone marrow and that specific humoral immunity may be transferred from donor to recipi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Slifka MK,Whitmire JK,Ahmed R

    更新日期:1997-09-01 00:00:00

  • ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy.

    abstract::We report 3 cases of a previously uncharacterized form of histiocytosis presenting in early infancy and showing ALK immunoreactivity. The patients presented with pallor, massive hepatosplenomegaly, anemia, and thrombocytopenia. Liver biopsy showed infiltration of the sinusoids by large histiocytes with markedly folded...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-03-147017

    authors: Chan JK,Lamant L,Algar E,Delsol G,Tsang WY,Lee KC,Tiedemann K,Chow CW

    更新日期:2008-10-01 00:00:00

  • Biology and management of primary effusion lymphoma.

    abstract::Primary effusion lymphoma (PEL) is a rare B-cell malignancy that most often occurs in immunocompromised patients, such as HIV-infected individuals and patients receiving organ transplantation. The main characteristic of PEL is neoplastic effusions in body cavities without detectable tumor masses. The onset of the dise...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-03-791426

    authors: Shimada K,Hayakawa F,Kiyoi H

    更新日期:2018-11-01 00:00:00

  • Cytokine regulation of the human burst-forming unit-megakaryocyte.

    abstract::The human burst-forming unit-megakaryocyte (BFU-MK) is a primitive megakaryocytic progenitor cell. A marrow cell population enriched for BFU-MK (CD34+ DR-) was obtained by monoclonal antibody labeling and fluorescence-activated cell sorting. CD34+DR- cells were assayed in a serum-depleted, fibrin clot culture system. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Briddell RA,Hoffman R

    更新日期:1990-08-01 00:00:00

  • An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults.

    abstract::We have used a single intensive chemotherapy regimen in the treatment of young patients with diffuse, aggressive, malignant lymphomas. There were two major histologic types of lymphoma in our series: lymphoblastic lymphomas, which presented most often with mediastinal tumor (64%), and undifferentiated lymphomas (mostl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Magrath IT,Janus C,Edwards BK,Spiegel R,Jaffe ES,Berard CW,Miliauskas J,Morris K,Barnwell R

    更新日期:1984-05-01 00:00:00

  • Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs.

    abstract::Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene on the X-chromosome that result in skeletal and cardiac muscle damage and premature death. Studies in mice, including the mdx mouse model of DMD, have demonstrated that circulating bone marrow-derived cells can participate in skeletal musc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-06-2247

    authors: Dell'Agnola C,Wang Z,Storb R,Tapscott SJ,Kuhr CS,Hauschka SD,Lee RS,Sale GE,Zellmer E,Gisburne S,Bogan J,Kornegay JN,Cooper BJ,Gooley TA,Little MT

    更新日期:2004-12-15 00:00:00

  • Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies.

    abstract::CD20 is a nonglycosylated 33 to 37 kD phosphoprotein involved in B-cell signaling that subserves important functions in the regulation of B-cell proliferation and differentiation. In addition, this B-cell surface antigen has been shown recently to be an effective target for immunotherapy of B-cell malignancies using c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Shan D,Ledbetter JA,Press OW

    更新日期:1998-03-01 00:00:00

  • Acquired von Willebrand's disease in association with Wilm's tumor: regression following treatment.

    abstract::A 9-yr-old female presented with a Wilm's tumor and a coagulopathy consistent with von Willebrand's disease. Factor VIII procoagulant activity (VIII C), factor VIII related antigen (VIIIR:Ag), and von Willebrand factor activity (VIII:vWf) were decreased. There was no evidence for a circulating inhibitor of the factor ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Scott JP,Montgomery RR,Tubergen DG,Hays T

    更新日期:1981-10-01 00:00:00

  • The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis.

    abstract::ADAMTS13 proteolytically regulates the platelet-tethering function of von Willebrand factor (VWF). ADAMTS13 function is dependent upon multiple exosites that specifically bind the unraveled VWF A2 domain and enable proteolysis. We carried out a comprehensive functional analysis of the ADAMTS13 cysteine-rich (Cys-rich)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-08-594556

    authors: de Groot R,Lane DA,Crawley JT

    更新日期:2015-03-19 00:00:00

  • Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol.

    abstract::The combination of high levels of beta2-microglobulin (beta2-m) and chromosome 13 deletion allows identification of a high-risk subgroup of patients with de novo multiple myeloma (MM). In this population of patients, we have evaluated the impact of a murine anti-interleukin 6 (anti-IL-6) monoclonal antibody (BE-8) as ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2005-06-2573

    authors: Moreau P,Hullin C,Garban F,Yakoub-Agha I,Benboubker L,Attal M,Marit G,Fuzibet JG,Doyen C,Voillat L,Berthou C,Ketterer N,Casassus P,Monconduit M,Michallet M,Najman A,Sotto JJ,Bataille R,Harousseau JL,Intergroupe Fran

    更新日期:2006-01-01 00:00:00

  • Successful bone marrow transplantation against mixed lymphocyte culture barrier.

    abstract::If bone marrow transplantation is to become widely applicable in the treatment of patients with leukemia and aplastic anemia, the necessity to have a perfectly histocompatible donor must be overcome. In an effort to define the roles of HL-A type and mixed lymphocyte culture (MLC) reactivity in the determination of suc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Feig SA,Opelz G,Winter HS,Falk PM,Neerhout RC,Sparkes R,Gale RP

    更新日期:1976-09-01 00:00:00

  • Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.

    abstract::Leukemia relapse is a major cause of treatment failure for patients with acute leukemia given allogeneic bone marrow transplantation (BMT). This study evaluated whether a reduction of the dosage of cyclosporine-A (Cs-A) used for graft versus host disease (GVHD) prophylaxis could reduce relapse rate (RR) in children wi...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Locatelli F,Zecca M,Rondelli R,Bonetti F,Dini G,Prete A,Messina C,Uderzo C,Ripaldi M,Porta F,Giorgiani G,Giraldi E,Pession A

    更新日期:2000-03-01 00:00:00

  • Cyclosporin-A is selectively cytotoxic to human leukemic T cells in vitro.

    abstract::We have studied the antileukemic effects of cyclosporin-A (CyA) on the cells of a number of human hematopoietic biopsies and established cell lines in vitro. Cya killed the tumor cells but not the nonmalignant control cells from three of four patients with T-lymphocytic leukemia/lymphoma at concentrations comparable t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tötterman TH,Danersund A,Nilsson K,Killander A

    更新日期:1982-05-01 00:00:00

  • Minimal residual disease is an independent predictor for 10-year survival in CLL.

    abstract::Minimal residual disease (MRD) negativity, defined as <1 chronic lymphocytic leukemia (CLL) cell detectable per 10 000 leukocytes, has been shown to independently predict for clinical outcome in patients receiving combination chemoimmunotherapy in the frontline setting. However, the long-term prognostic value of MRD s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-05-714162

    authors: Kwok M,Rawstron AC,Varghese A,Evans PA,O'Connor SJ,Doughty C,Newton DJ,Moreton P,Hillmen P

    更新日期:2016-12-15 00:00:00

  • Posttranslational processing of a human myeloid lysosomal protein, myeloperoxidase.

    abstract::Myeloperoxidase (MPO) is a lysosomal enzyme present in the azurophilic granules of human neutrophils and monocytes and is important for optimal oxygen-dependent killing of microorganisms. The native molecule is a heterodimer composed of a pair of heavy-light protomers, each containing a 59-kDa and 13.5-kDa subunit. Th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nauseef WM

    更新日期:1987-10-01 00:00:00

  • Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes.

    abstract::To determine the risk factors and outcomes associated with rising cytomegalovirus (CMV) antigenemia levels during preemptive therapy among stem cell allograft recipients, 119 patients with CMV antigenemia were studied. Patients were prospectively monitored for CMV antigenemia weekly; those with positive findings on an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.4.867

    authors: Nichols WG,Corey L,Gooley T,Drew WL,Miner R,Huang M,Davis C,Boeckh M

    更新日期:2001-02-15 00:00:00

  • T cell chronic lymphocytic leukemia with lymphocytes of unusual immunologic phenotype and function.

    abstract::This report discusses a case of T cell chronic lymphocytic leukemia (T-CLL) in an elderly white man whose lymphocytes expressed a post-thymic phenotype except for the coexpression of T4 and T8 on 80% to 95% of the cells. Because of the uncommon phenotype, in vitro functional assays were performed that showed decreased...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Simpkins H,Kiprov DD,Davis JL 3rd,Morand P,Puri S,Grahn EP

    更新日期:1985-01-01 00:00:00